Tofacitinib For Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

被引:0
|
作者
Lopez-Olivo, Maria A. [1 ]
Suarez-Almazor, Maria E. [1 ]
Bavineni, Mahesh [2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Louisiana State Univ, Lafayette, LA USA
来源
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1471
引用
收藏
页码:S625 / S625
页数:1
相关论文
共 50 条
  • [1] Safety of Tofacitinib in the Treatment of Rheumatoid Arthritis: a Systematic Review and Meta-Analysis
    He, Y.
    Wong, A.
    Chan, E.
    Lau, W.
    Man, K.
    Chui, C.
    Worsley, A.
    Wong, I.
    [J]. DRUG SAFETY, 2013, 36 (09) : 852 - 853
  • [2] Efficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
    He, Ying
    Wong, Angel Y. S.
    Chan, Esther W.
    Lau, Wallis C. Y.
    Man, Kenneth K. C.
    Chui, Celine S. L.
    Worsley, Alan J.
    Wong, Ian C. K.
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2013, 14
  • [3] Efficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
    Ying He
    Angel YS Wong
    Esther W Chan
    Wallis CY Lau
    Kenneth KC Man
    Celine SL Chui
    Alan J Worsley
    Ian CK Wong
    [J]. BMC Musculoskeletal Disorders, 14
  • [4] Efficacy and Safety of Tofacitinib, Baricitinib, and Upadacitinib for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
    Wang, Faping
    Sun, Ling
    Wang, Shaohua
    Davis, John M.
    Matteson, Eric L.
    Murad, M. Hassan
    Luo, Fengming
    Vassallo, Robert
    [J]. MAYO CLINIC PROCEEDINGS, 2020, 95 (07) : 1404 - 1419
  • [5] Risks of malignancies related to tofacitinib and biological drugs in rheumatoid arthritis: Systematic review, meta-analysis, and network meta-analysis
    Ramon Maneiro, Jose
    Souto, Alejandro
    Gomez-Reino, Juan J.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 47 (02) : 149 - 156
  • [6] Efficacy and safety of tofacitinib combined with methotrexate in the treatment of rheumatoid arthritis: A systematic review and meta-analysis
    Gao, Yan
    Gao, Yi-ni
    Wang, Mei-jiao
    Zhang, Yi
    Zhang, Feng-qi
    He, Zhi-xing
    Chen, Wu
    Li, Hai-chang
    Xie, Zhi-jun
    Wen, Cheng-ping
    [J]. HELIYON, 2023, 9 (05)
  • [7] Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis
    Singh, Jasvinder A.
    Hossain, Alomgir
    Mudano, Amy S.
    Ghogomu, Elizabeth Tanjong
    Suarez-Almazor, Maria E.
    Buchbinder, Rachelle
    Maxwell, Lara J.
    Tugwell, Peter
    Wells, George A.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (05):
  • [8] The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
    Kawalec, Pawel
    Mikrut, Alicja
    Wisniewska, Natalia
    Pilc, Andrzej
    [J]. CLINICAL RHEUMATOLOGY, 2013, 32 (10) : 1415 - 1424
  • [9] The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
    Paweł Kawalec
    Alicja Mikrut
    Natalia Wiśniewska
    Andrzej Pilc
    [J]. Clinical Rheumatology, 2013, 32 : 1415 - 1424
  • [10] Cost-effectiveness analysis of tofacitinib for the treatment of moderate to severe rheumatoid arthritis: a systematic review and meta-analysis
    Fatemi, Behzad
    Yaghobi, Neda
    Shobeiri, Nikta
    Ahmadi, Razieh
    Mousavi, Taraneh
    Soleymani, Fatemeh
    Rezaei, Soheila
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2024,